Bank of New York Mellon’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $818M | Sell |
4,197,610
-727,776
| -15% | -$151M | 0.13% | 137 |
|
|
2026
Q1 | $1.11B | Buy |
4,925,386
+34,732
| +0.7% | +$8.66M | 0.2% | 96 |
|
|
2025
Q4 | $1.18B | Buy |
4,890,654
+337,738
| +7% | +$86.4M | 0.21% | 89 |
|
|
2025
Q3 | $1.25B | Sell |
4,552,916
-492,643
| -10% | -$135M | 0.22% | 83 |
|
|
2025
Q2 | $1.3B | Sell |
5,045,559
-158,658
| -3% | -$37.8M | 0.25% | 77 |
|
|
2025
Q1 | $1.16B | Sell |
5,204,217
-227,689
| -4% | -$53.2M | 0.23% | 83 |
|
|
2024
Q4 | $1.24B | Sell |
5,431,906
-276,548
| -5% | -$66.6M | 0.23% | 80 |
|
|
2024
Q3 | $1.39B | Sell |
5,708,454
-64,307
| -1% | -$14.4M | 0.26% | 71 |
|
|
2024
Q2 | $1.11B | Buy |
5,772,761
+1,959,642
| +51% | +$398M | 0.21% | 91 |
|
|
2024
Q1 | $755M | Buy |
3,813,119
+2,658,709
| +230% | +$487M | 0.15% | 138 |
|
|
2023
Q4 | $199M | Buy |
1,154,410
+15,432
| +1% | +$2.37M | 0.04% | 375 |
|
|
2023
Q3 | $168M | Sell |
1,138,978
-48,738
| -4% | -$8.81M | 0.04% | 408 |
|
|
2023
Q2 | $260M | Sell |
1,187,716
-72,293
| -6% | -$16.1M | 0.05% | 315 |
|
|
2023
Q1 | $276M | Buy |
1,260,009
+17,283
| +1% | +$3.75M | 0.06% | 289 |
|
|
2022
Q4 | $259M | Sell |
1,242,726
-25,694
| -2% | -$5.65M | 0.06% | 292 |
|
|
2022
Q3 | $277M | Sell |
1,268,420
-26,276
| -2% | -$5.98M | 0.07% | 261 |
|
|
2022
Q2 | $271M | Buy |
1,294,696
+29,713
| +2% | +$6.33M | 0.06% | 285 |
|
|
2022
Q1 | $307M | Sell |
1,264,983
-29,599
| -2% | -$7.16M | 0.06% | 294 |
|
|
2021
Q4 | $337M | Sell |
1,294,582
-319
| -0% | -$82.8K | 0.06% | 283 |
|
|
2021
Q3 | $341M | Sell |
1,294,901
-74,961
| -5% | -$20.5M | 0.07% | 264 |
|
|
2021
Q2 | $338M | Sell |
1,369,862
-48,126
| -3% | -$10.1M | 0.07% | 268 |
|
|
2021
Q1 | $275M | Buy |
1,417,988
+4,164
| +0.3% | +$835K | 0.06% | 299 |
|
|
2020
Q4 | $301M | Sell |
1,413,824
-34,707
| -2% | -$6.92M | 0.07% | 262 |
|
|
2020
Q3 | $248M | Buy |
1,448,531
+152,454
| +12% | +$28.2M | 0.06% | 275 |
|
|
2020
Q2 | $249M | Buy |
1,296,077
+54,252
| +4% | +$8.88M | 0.07% | 251 |
|
|
2020
Q1 | $183M | Sell |
1,241,825
-3,858
| -0.3% | -$614K | 0.06% | 279 |
|
|
2019
Q4 | $193M | Sell |
1,245,683
-7,455
| -0.6% | -$1.07M | 0.05% | 339 |
|
|
2019
Q3 | $169M | Buy |
1,253,138
+4,393
| +0.4% | +$576K | 0.05% | 354 |
|
|
2019
Q2 | $152M | Sell |
1,248,745
-85,998
| -6% | -$9.53M | 0.04% | 412 |
|
|
2019
Q1 | $139M | Sell |
1,334,743
-32,426
| -2% | -$3.35M | 0.04% | 442 |
|
|
2018
Q4 | $156M | Sell |
1,367,169
-265,602
| -16% | -$28.5M | 0.05% | 358 |
|
|
2018
Q3 | $188M | Buy |
1,632,771
+11,927
| +0.7% | +$1.31M | 0.05% | 367 |
|
|
2018
Q2 | $168M | Sell |
1,620,844
-40,894
| -2% | -$4.14M | 0.05% | 383 |
|
|
2018
Q1 | $164M | Sell |
1,661,738
-46,128
| -3% | -$4.36M | 0.05% | 401 |
|
|
2017
Q4 | $145M | Sell |
1,707,866
-43,695
| -2% | -$3.61M | 0.04% | 458 |
|
|
2017
Q3 | $135M | Sell |
1,751,561
-515,102
| -23% | -$39.4M | 0.04% | 465 |
|
|
2017
Q2 | $177M | Buy |
2,266,663
+25,925
| +1% | +$1.85M | 0.05% | 383 |
|
|
2017
Q1 | $161M | Sell |
2,240,738
-82,903
| -4% | -$5.73M | 0.04% | 413 |
|
|
2016
Q4 | $144M | Sell |
2,323,641
-64,860
| -3% | -$3.97M | 0.04% | 439 |
|
|
2016
Q3 | $155M | Sell |
2,388,501
-63,465
| -3% | -$4.22M | 0.05% | 392 |
|
|
2016
Q2 | $155M | Sell |
2,451,966
-24,103
| -1% | -$1.42M | 0.05% | 382 |
|
|
2016
Q1 | $143M | Buy |
2,476,069
+98,579
| +4% | +$5.58M | 0.04% | 403 |
|
|
2015
Q4 | $128M | Sell |
2,377,490
-20,421
| -0.9% | -$1.15M | 0.04% | 439 |
|
|
2015
Q3 | $122M | Buy |
2,397,911
+238,466
| +11% | +$12.8M | 0.04% | 461 |
|
|
2015
Q2 | $122M | Sell |
2,159,445
-30,771
| -1% | -$1.94M | 0.03% | 497 |
|
|
2015
Q1 | $157M | Buy |
2,190,216
+11,864
| +0.5% | +$771K | 0.04% | 437 |
|
|
2014
Q4 | $122M | Sell |
2,178,352
-201,565
| -8% | -$10.5M | 0.03% | 518 |
|
|
2014
Q3 | $117M | Sell |
2,379,917
-121,147
| -5% | -$6.17M | 0.03% | 518 |
|
|
2014
Q2 | $127M | Sell |
2,501,064
-843,186
| -25% | -$41.8M | 0.03% | 497 |
|
|
2014
Q1 | $149M | Sell |
3,344,250
-24,606
| -0.7% | -$1.11M | 0.04% | 440 |
|
|
2013
Q4 | $159M | Buy |
3,368,856
+64,899
| +2% | +$3.29M | 0.04% | 408 |
|
|
2013
Q3 | $175M | Sell |
3,303,957
-17,308
| -0.5% | -$840K | 0.05% | 370 |
|
|
2013
Q2 | $150M | Buy |
+3,321,265
| New | +$158M | 0.05% | 397 |
|
Other funds holding RMD
Bank of New York Mellon's RMD Position: Q2 2026 in Review
Bank of New York Mellon reduced its ResMed (RMD) stake by 15% in Q2 2026, selling an estimated $151M and leaving 4,197,610 shares worth $818M. The position accounts for 0.13% of the portfolio, ranked #137.
Bank of New York Mellon first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.39B in Q3 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Bank of New York Mellon held 4,197,610 shares of ResMed worth $818M as of Q2 2026.
- Bank of New York Mellon sold 727,776 ResMed shares in Q2 2026, an estimated $151M.
- ResMed made up 0.13% of Bank of New York Mellon's portfolio in Q2 2026, its #137 holding.
- Bank of New York Mellon first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's ResMed position peaked at $1.39B in Q3 2024.
- 885 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.